We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(AACR) Oct 16, 2018 - Chanita Hughes-Halbert, PhD, is the recipient of the 2018 AACR Distinguished Lecture on the Science of Cancer Health Disparities, funded by Susan G. Komen, the American Association for Cancer Research (AACR) announced today.
(Journal of Clinical Pathways/Reuters Health) Oct 16, 2018 - Oral cancer pain level at the primary site may help doctors identify which patients with occult metastases will benefit from neck dissection, according to results of a study by researchers at New York University in New York City.
(New York Times) Oct 16, 2018 - The psychologist Carol Gilligan and the poet Jorie Graham offer praise for the cancer doctor José Baselga.
(Walter + Eliza Hall Institute [Australia]) Oct 17, 2018 - Cancer patients could be spared unnecessary chemotherapy – and its side-effects – by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.
(Forbes) Oct 17, 2018 - UnitedHealth Group says it’s paying almost half of its annual reimbursements – or $69 billion – to doctors and hospitals via value-based care models quickly replacing fee-for-service medicine in the U.S.
(HCI) Oct 16, 2018 - In lung cancer study, tumor cells influence immune cells in their surroundings.
(KHN) Oct 16, 2018 - The Trump administration’s top Medicare official Tuesday slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.
(NASDAQ) Oct 16, 2018 - Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® to be used by healthcare professionals to identify patients with HER2-negative metastatic breast cancer (mBC) who have a germline BRCA mutation and are eligible for treatment with Pfizer's PARP (poly ADP ribose polymerase) inhibitor, TALZENNA® (talazoparib).
(Wall Street Journal) Oct 16, 2018 - Cheaper copies of AbbVie’s Humira will roll out across Europe after a key European patent expires, but U.S. patients will have to wait to access less-expensive versions of the blockbuster drug.
(ASTRO) Oct 17, 2018 - In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer. The findings will be presented in a news briefing and the plenary session at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO) next week.